Overview

Interactions of Hepatitis C Viral (HCV) Dynamics and Immune Activation in HIV Coinfected Patients During HCV Treatment

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate T-cell mediated immune responses to HIV-1 and HCV and determine how these responses are affected by HCV treatment and correlates to response. Furthermore, to study Interferon-inducible protein-10 (IP-10) dynamics during HCV treatment, and correlate this to treatment outcome.
Phase:
N/A
Details
Lead Sponsor:
Karolinska Institutet
Collaborators:
Hoffmann-La Roche
The Swedish Research Council
Treatments:
Interferon-alpha
Interferons
Peginterferon alfa-2a
Ribavirin